ClinicalTrials.gg
RecruitingNCT06449807Updated Jun 10, 2024

Effects of Crossover Point Exercise on Depression, Anxiety and Stress in Chinese Postmenopausal Women

An interventional study of crossover point intensity exercise in Mental Health, sponsored by Beijing Sport University. Recruiting at 1 site in China. Open to female participants aged 45 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-10.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Beijing Sport University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
45 Years to 70 Years
Sex
Female
01

Study summary

To analyze the effects of the Crossover Point (COP) Exercise Program on Chinese postmenopausal women.

Read the detailed description

This is a randomized clinical trial of single-blind with 2 arms (control group and experimental group), in which a pre-treatment-posttest design has been used.

02

Conditions studied

  • Mental Health

Keywords

  • Mental health
  • Sleep quality
  • Exercise
  • Body composition
  • Body image
03

In context

Psychological Well-Being Unverified

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

This study's planned enrollment of 80 is below the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Beijing Sport University is the lead sponsor of 56 studies on the registry; 10 are open to participants now.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
45 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women without incapacitating chronic disease or to exercise
  • baseline mental health
  • no severe chronic diseases or exercise contraindications
  • ability to understand the research details and voluntarily sign the form.

Exclusion criteria

Exclusion Criteria:

  • Women with undetermined menopause;
  • \<18.5 kg/m2 or BMI >28 kg/m2
  • uncontrolled hypertension (systolic blood pressure >160 mmHg and/or diastolic blood pressure >110 mmHg)
  • life-threatening illness with a prognosis of \<5 years
  • currently receiving estrogen therapy
  • currently taking medication that may affect psychological testing
  • to exercise
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    crossover point intensity exercise

    Behavioral: crossover point intensity exercise

  • No intervention
    No Intervention

Interventions

  • Behavioralcrossover point intensity exercise

    crossover point intensity exercise

06

What researchers measure

Primary outcomes

  1. DASS-21 (Depression Anxiety Stress Scale-21)

    The scale has 21 questions that cover a wide range of symptoms of depression, anxiety, and stress. Each of the questions was stated in the first person, assertive tone, and required the participants to grade on a 4-point scale their experiences with a score of 0 (did not apply to me at all), 1 (applied to me to some degree or some of the time), 2 (applied to me to a considerable degree or a good part of the time), and 3 (applied to me very much or most of the time). The higher value represents a worse result.

    Time frame: At the beginning-at three months.

Secondary outcomes

  1. Body Mass Index (BMI )

    Is calculated from the formula, Weight (kg) / Height2 (m2), whose unit is kg/m2. It is a rough indicator of total body fat.

    Time frame: At the beginning-at three months.

  2. Body Image States Scale (BISS)

    The BISS contains six items that assess different aspects of body image such as physical appearance, body size and shape, body weight, and attractiveness, as well as concerns about how one looks relative to others. Participants were instructed to complete the questionnaire describing ''How are you feeling right now?'' A higher score represents higher body image satisfaction. The BISS is an internally consistent scale, and construct validity has been confirmed.

    Time frame: At the beginning-at three months.

  3. Body Appreciation Scale-2 (BAS-2)

    The BAS-2 used in this study is the version revised by Swami et al., it comprises a total of 10 items, scored using a Likert five-point scale, corresponding to the options "Never, Rarely, Sometimes, Often, Always," with each item scored from 1 to 5 points. A higher score indicates a stronger appreciation of one's own body.

    Time frame: At the beginning-at three months.

  4. The Meaning in Life Questionnaire (MLQ)

    A reliable, valid and practical screening tool for identifying and quantifying Meaning in Life.

    Time frame: At the beginning-at three months.

  5. The Subjective Happiness Scale (SMS)

    Questionnaire that evaluates the subjective happiness.

    Time frame: At the beginning-at three months.

  6. Body composition

    Body composition indicators analysis was assessed using DXA. Body compositon indicators include: fat mass,lean body mass,percentage of body fat.

    Time frame: At the beginning-at three months.

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Sep 2024, 7 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 7 months is below that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2024
First posted
Jun 10, 2024
StartActual
Feb 20, 2024
Primary completionEst.
Sep 30, 2024
CompletionEst.
Dec 31, 2024
Last update
Jun 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06449807
Lead sponsor
Beijing Sport University
Responsible party
Sponsor
First posted
Jun 10, 2024
Start date
Feb 20, 2024
Primary completion
Sep 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Jun 10, 2024

Study contacts

Peizhen Zhang
Contact
zhpzh@bsu.edu.cn
01062989581

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion